About Immune Control
Immune Control is a company based in Conshohocken (United States) founded in 2001. Immune Control has raised $11.3 million across 2 funding rounds from investors including Broadmark Realty Capital, BioAdvance and NewSpring Capital. Immune Control operates in a competitive market with competitors including AmerisourceBergen, Renee, Apothkary, AvKARE and Cencora, among others.
- Headquarter Conshohocken, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$11.3 M (USD)
in 2 rounds
-
Latest Funding Round
$11.3 M (USD), Series A
Jul 13, 2005
-
Investors
Broadmark Realty Capital
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Immune Control
Immune Control has successfully raised a total of $11.3M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $11.3 million completed in July 2005. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Immune Control
Immune Control has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Broadmark Realty Capital, BioAdvance and NewSpring Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Investment firm focusing on lower-middle market growth, healthcare, and various strategies.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Immune Control
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Immune Control
Investment portfolio details for Immune Control
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Immune Control
Detailed financials for Immune Control
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Immune Control Comparisons
Peer comparison for Immune Control
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Immune Control
Immune Control operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, Renee, Apothkary, AvKARE and Cencora, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical distribution and supply chain services are provided globally.
|
|
| Locked | Locked | Locked |
Diversified drugs are distributed by Renee in the United States.
|
|
| Locked | Locked | Locked |
Provides herbal formulas for stress relief, energy, mood, and wellness support.
|
|
| Locked | Locked | Locked |
Pharmaceuticals and infection control products are distributed by AvKARE.
|
|
| Locked | Locked | Locked |
Clinical trial logistics and biopharma outsourcing services are provided globally.
|
Detailed competitors of Immune Control
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Immune Control
Complete news archive for Immune Control
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Immune Control
Immune Control was founded in 2001 and raised its 1st funding round 4 years after it was founded.
Immune Control is headquartered in Conshohocken, United States. It is registered at Conshohocken, Pennsylvania, United States.
Immune Control is a funded company, having raised a total of $11.3M across 2 funding rounds to date.
Immune Control, established in 2001, excels in providing healthcare solutions, pharmaceutical distributors, and diversified. Limited information available. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide. It continues to evolve, meeting industry challenges with strategic approaches.
Immune Control's top competitors include AmerisourceBergen, AvKARE and Cencora.
Immune Control has 5 investors. Key investors include Broadmark Realty Capital, BioAdvance, NewSpring Capital, Anthem Capital, and Domain Associates.